CREATION Knowledge

31.10.2023 | Webinars

Identify your Rising Star DOLs

This webinar will look at the next step in DOL engagement – identifying HCP Rising Star DOLs

By Katie Kennedy and Mark Sullivan

27.09.2023 | Article

Healthcare professionals celebrate new data in diabetic kidney disease

In the lead up to ADA 2023, eHCPs discussed treatments and trials related to DKD

By Cameron Bassindale

21.09.2023 | Article

Respiratory tracker: NHS England’s #AskAboutAsthma got eHCPs talking in September

Bringing you the latest insights into online HCPs' respiratory disease related conversation

By Cameron Bassindale

19.09.2023 | Article

Can social listening support your omnichannel approach?

Find out how social media listening can help your omnichannel strategy

By Katie Kennedy

19.09.2023 | Article

The social media impact of top-10 pharma’s CEOs

CREATION.co looks at the social media use of CEOs at the top 10 pharma companies

By Cameron Bassindale

08.09.2023 | Article

Ensuring continuous digital transformation

What is digital transformation and how can pharma ensure continuous digital transformation?

By Anni Neumann

01.09.2023 | Article

Top 50 Pharma Tracker: Novo Nordisk’s semaglutide trial gets praise from HCPs

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

25.08.2023 | Case Study

Developing a bespoke global playbook for DOLs

An interactive DOL playbook was developed & designed, providing guidelines for global teams

25.08.2023 | Article

eHCPs in the Netherlands say smoking cessation is more critical than lung…

What eHCPs in the Netherlands are conversing about online within lung cancer

By Mary Kangley

23.08.2023 | Article

Consultants striking: What eHCPs think of the new industrial action

What eHCPs think about the NHS consultant strike action

By Alexandra Maria Chatziioannidou

21.08.2023 | Article

Respiratory tracker: Legionella bacteria in the Bibby Stockholm barge causes concern in…

Bringing you the latest insights into online HCPs' respiratory disease related conversation

By Hannah Ghinn

11.08.2023 | Article

Online conversations suggest US HCPs are not yet convinced about Daiichi Sankyo’s…

What eHCPs think of the FDA approved the use of Vanflyta, as an FTL3 inhibitor

By Hannah Ghinn